ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

ClinicalTrials.gov ID: NCT04305613

Public ClinicalTrials.gov record NCT04305613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy: A Prospective Longitudinal Cohort

Study identification

NCT ID
NCT04305613
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Abramson Cancer Center at Penn Medicine
Other
Enrollment
221 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 13, 2020
Primary completion
Aug 31, 2026
Completion
Nov 30, 2030
Last update posted
Oct 1, 2025

2020 – 2030

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233
The Brigham and Women's Hospital Boston Massachusetts 02115
Washington University School of Medicine St Louis Missouri 63110
Rutger's University / Cancer Institute of New Jersey New Brunswick New Jersey 08901
Montefiore Medical Center The Bronx New York 190467
Lancaster General Hospital Lancaster Pennsylvania 17601
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104
Chester County Hospital West Chester Pennsylvania 19380

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04305613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04305613 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →